Investigation of the potential of clozapine to cause torsade de pointes. - Wikidata - wikimedia - TriplyDB

Investigation of the potential of clozapine to cause torsade de pointes.

Investigation of the potential of clozapine to cause torsade de pointes.

http://www.wikidata.org/entity/Q35034866

about

QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management An analysis of QTc prolongation with atypical antipsychotic medications and selective serotonin reuptake inhibitors using a large ECG record database.Assessing QT interval prolongation and its associated risks with antipsychotics.The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres.Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation.Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias.Secondary effects of antipsychotics: women at greater risk than men.Antipsychotic-induced QTc interval prolongation.Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.[Lengthening of QT interval by antipsychotic drugs].Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.Clozaphobia: Fear of Prescribers of Clozapine for Treatment of Schizophrenia

P2860

Q27015763-253793F3-8F2C-4B6A-B4D2-B1EDA0FDB8D9 Q28268128-CF229363-EE02-49C0-A94F-4DC13B9351E2 Q30489429-C2C4B55D-0129-4BBB-BCFF-0EC4117F1C36 Q33160123-86CF8517-2FB8-428C-9F0F-AB0E4DCB8B01 Q33566124-D968FE46-E836-40B8-8CCE-0BC51D278C82 Q35048591-59574891-5399-449C-9F64-11F121B48C7D Q35698299-69C56769-BD08-41A3-9F95-DF2A4C165DE6 Q35955904-FE93DEB6-0619-4149-825B-CE1AE0CFF8F3 Q37133664-3AD419C4-2443-4D89-BF5E-3F473FAA2DF8 Q45123207-7046670B-86B1-4DDC-9931-E8391A8EB57F Q51507196-5C9BFF99-9F32-44DE-99FC-6C460DBA5A20 Q52937398-3EDF4479-AA9F-406C-83C3-161281AAFD6E Q55232340-DB82C29A-3825-4993-9B3C-19CE3F1A18EB Q57820263-008BA5D7-7DC9-482D-8DD0-7AF3038F1C9E

P2860

Investigation of the potential of clozapine to cause torsade de pointes.

http://www.wikidata.org/entity/Q35034866

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Investigation of the potential of clozapine to cause torsade de pointes.

@ast

Investigation of the potential of clozapine to cause torsade de pointes.

@en

type

label

Investigation of the potential of clozapine to cause torsade de pointes.

@ast

Investigation of the potential of clozapine to cause torsade de pointes.

@en

prefLabel

Investigation of the potential of clozapine to cause torsade de pointes.

@ast

Investigation of the potential of clozapine to cause torsade de pointes.

@en

P1433

Q35034866-7E54C055-600E-456E-8096-FBB771ACD949

P1476

Q35034866-5B434C60-B4DB-4A04-AA45-05FC0107F70A

P2093

Q35034866-25D0AF70-074F-4393-A2B4-D03DD6CFEDBE

Q35034866-CF05ED53-1D6E-48E5-BF8C-2A35B3D8EF4B

P2860

Q35034866-00327C22-9F43-4755-B516-2EB67101E982

Q35034866-0D6AECE6-472A-4800-B993-FF5B7317BDEB

Q35034866-13F9138C-03C5-49BC-9B20-9394134569AB

Q35034866-20F223C3-0988-4BF5-BB72-568DF442FB27

Q35034866-2ADAE996-D13C-4AC6-A44F-056D97870A51

Q35034866-34407F35-A4C0-41F2-87B5-6505EFED7364

Q35034866-3955A171-7AFC-4770-BF1B-E1074EC4E4CC

Q35034866-5E353C37-1918-4BC9-B039-4AA6FDDEC9FC

Q35034866-655906F8-1F37-4079-A41C-3C122B44E527

Q35034866-65CA7E20-303D-4DC1-9CFC-0762936075B3

P2888

Q35034866-8C86F069-388B-47DE-98EC-B84631475E2F

P304

Q35034866-6D5A9ED9-7830-4769-BEB3-F3B821F5FBAA

P31

Q35034866-49C7426D-882C-45A1-8B18-3F595E233446

P356

Q35034866-9551FE1F-71C6-4FB0-996A-965F05EF4381

P433

Q35034866-C4CC41FB-4554-417A-8A95-1061A18EC802

P478

Q35034866-940687C0-0F6F-4176-9C2E-E7E153B03602

P577

Q35034866-69484136-218C-46E0-8674-3BCE26D7C0D3

P698

Q35034866-F818FE97-9542-49E7-ACCA-E0C8E505E9C8

P356

P1433

Toxicological Reviews

P1476

Investigation of the potential of clozapine to cause torsade de pointes.

@en

P2093

Barbara Warner

http://www.w3.org/2001/XMLSchema#string

Peter Hoffmann

http://www.w3.org/2001/XMLSchema#string

P2860

Transient syncope and ECG changes associated with the concurrent administration of clozapine and diazepam

Myocarditis and cardiomyopathy associated with clozapine

Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial.

Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.

Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study.

Sudden death in patients receiving clozapine treatment: a preliminary investigation.

The assessment of potential for QT interval prolongation with new pharmaceuticals: impact on drug development.

Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias.

HERG K+ channels: friend and foe.

Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival.

P2888

P304

189-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03256196

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12503253

http://www.w3.org/2001/XMLSchema#string